Clinical and Experimental Reproductive Medicine-CERM
Scope & Guideline
Empowering Practitioners with Cutting-Edge Insights
Introduction
Aims and Scopes
- Reproductive Health Research:
CERM publishes studies related to reproductive health, including fertility, infertility treatments, and reproductive endocrinology, addressing both male and female reproductive systems. - Innovative Treatment Modalities:
The journal highlights novel therapeutic approaches and interventions in reproductive medicine, such as the use of stem cells, hormonal therapies, and nutritional supplements. - Clinical and Experimental Studies:
CERM features both clinical trials and experimental studies, bridging the gap between laboratory research and clinical applications to improve patient care. - Metabolic and Genetic Factors in Reproduction:
Research on the influence of metabolic syndromes and genetic predispositions on reproductive health is a key focus, exploring how these factors impact fertility and reproductive outcomes. - Environmental and Lifestyle Impacts:
The journal examines the effects of environmental toxins, lifestyle choices, and public health issues, such as the COVID-19 pandemic, on reproductive health.
Trending and Emerging
- Metabolomics and Biomarkers:
Research utilizing metabolomic profiling to identify biomarkers for fertility and reproductive health is on the rise, offering insights into personalized treatment strategies. - Impact of COVID-19 on Reproductive Health:
The pandemic has prompted increased studies examining the implications of COVID-19 on fertility, reproductive outcomes, and the safety of assisted reproductive technologies. - Nutritional and Supplement Interventions:
There is a growing emphasis on the role of dietary supplements and nutritional interventions in enhancing fertility and reproductive health, particularly in populations with specific deficiencies. - Artificial Intelligence in Reproductive Medicine:
The implementation of AI-driven technologies for optimizing IVF procedures and predicting patient outcomes is an emerging trend, showcasing the integration of technology in reproductive practices. - Environmental and Lifestyle Influences:
Research focusing on the effects of environmental factors, such as pollutants and lifestyle choices on reproductive health, is gaining traction, reflecting a broader awareness of public health issues.
Declining or Waning
- Traditional Pharmacological Interventions:
Research focusing on conventional pharmacological treatments for reproductive health issues, such as hormone replacement therapies, appears to be waning as newer, more innovative treatments gain attention. - Animal Model Studies:
There is a noticeable decrease in studies solely reliant on animal models, indicating a shift towards human-centered research that prioritizes clinical relevance and applicability. - Invasive Surgical Procedures:
The exploration of invasive surgical techniques for fertility treatments is declining, likely due to advances in less invasive methods and the growing preference for minimally invasive approaches.
Similar Journals
Frontiers in Endocrinology
Pioneering Research in Diabetes and Endocrine HealthFrontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.
Reproduction and Fertility
Exploring the frontiers of fertility science.Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.
HUMAN REPRODUCTION
Advancing the frontiers of reproductive medicine.HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.
Gynakologische Endokrinologie
Exploring Innovations in Reproductive MedicineGynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.
Asian Pacific Journal of Reproduction
Innovating Reproductive Health in the Asian PacificAsian Pacific Journal of Reproduction is a dynamic open-access journal specializing in a diverse array of topics related to reproduction across various species, including humans, animals, and plants. Published by Wolters Kluwer Medknow Publications, this peer-reviewed journal has been committed to disseminating high-quality research since its inception in 2012. With an accessible ISBN of 2305-0500 and E-ISSN 2305-0519, the journal has rapidly established itself within the academic community, evidenced by its categorization in Q3 and Q4 quartiles across multiple fields, including Obstetrics, Gynecology, and Animal Science. Researchers are encouraged to contribute their findings to foster a deeper understanding of reproductive health and practices in the Asian Pacific region and beyond. The journal's inclusive scope and emphasis on interdisciplinary collaboration make it a crucial platform for professionals and scholars seeking to stay at the forefront of reproductive research.
ANDROLOGIA
Exploring the frontiers of andrology and urology.ANDROLOGIA is a distinguished journal published by Wiley, focusing on the vital fields of andrology, urology, and endocrinology. Since its inception in 1969, this journal has become a key resource for researchers, clinicians, and students, striving to advance the understanding of male reproductive health and related disorders. With an impressive impact factor and recognition in category quartiles such as Q2 in both Medicine (miscellaneous) and Urology for 2023, ANDROLOGIA has established itself as a leading platform, ranking 16th out of 120 in Urology. Though not an open-access journal, it offers valuable insights through a rigorous peer-review process and a commitment to disseminating high-quality research. The journal's scope is broad, encompassing all aspects of andrology and its implications within medicine, ensuring it remains relevant to the evolving landscape of health sciences. Researchers looking to publish their work or keep abreast of recent discoveries will find ANDROLOGIA an essential addition to their academic resources.
Reproductive Medicine
Unlocking Innovations in Fertility and WellnessReproductive Medicine is an esteemed open-access journal published by MDPI, focusing on the latest research and advances in reproductive health, fertility, and assisted reproductive technologies. With its E-ISSN of 2673-3897, the journal aims to provide a platform for researchers, clinicians, and healthcare professionals to disseminate their findings, share innovative practices, and engage in scholarly discourse. Situated in Basel, Switzerland, Reproductive Medicine emphasizes a multidisciplinary approach, exploring biological, clinical, and psychological aspects of reproductive health. Although the journal is in the early stages of establishing metrics such as H-index and Scopus rankings, its open-access model enhances accessibility, allowing for a broad dissemination of knowledge. Committed to fostering advancements in the field, Reproductive Medicine is essential for those seeking to stay at the forefront of reproductive health research.
ENDOCRINE RESEARCH
Illuminating the complexities of endocrinology.ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.
Hormone Molecular Biology and Clinical Investigation
Advancing Understanding in Endocrinology and MetabolismHormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.
Reproductive Medicine and Biology
Transforming knowledge into practice in reproductive health.Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.